Search results
Johnson & Johnson's Drug Seltorexant Aces Late-Stage Depression Trial
Benzinga via Yahoo Finance· 8 hours agoWednesday, Johnson & Johnson (NYSE:JNJ) announced topline results from Phase 3 MDD3001 clinical ...
BMS stakes $80m on Prothena’s neurodegenerative candidate
Pharmaceutical Technology via Yahoo Finance· 14 hours agoBMS’ Neuroscience Thematic Research Center...the US licence for Prothena’s PRX-005 for $80m in June...
Worldwide Clinical Trials' Peter Benton on the outlook for biopharma funding
BioPharma-Reporter· 7 days agoWhile the biopharma investment picture may not miraculously improve overnight, I expect we’ll see a...
FSD Pharma Submits a Clinical Trial Protocol to Study the Safety and Efficacy of Unbuzzd(TM) in...
Digital Journal· 1 day agoThe clinical trial protocol was submitted for review and approval by the institutional review board (IRB) in the USA...
Cystic fibrosis: global clinical trials landscape and treatments
Clinical Trials Arena via Yahoo Finance· 6 days agoAffecting more than 162,000 patients worldwide, cystic fibrosis affects respiratory health and...
... on Pilot Study Data from Phase 2 Combination Clinical Trial Evaluating Motixafortide in...
WKRN Nashville· 6 days ago...BLRX), a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today announced that an abstract including new data from the single-arm pilot phase of the investigator-initiated, randomized CheMo4METPANC Phase 2 combination clinical trial was...
Medical Device Coatings Company, Hydromer Inc, Launches New Product HydroThrombX
Digital Journal· 5 hours agoNorth of Soledar, Ukrainians yearn for peace Carlo Marks talks about his new Hallmark movie ‘The Wedding Veil Inspiration’ Musk faces US fraud trial over Tesla tweet Heat ...
Earnings call: CollPlant reports Q1 2024 results and corporate updates By Investing.com
Investing.com· 8 hours agoCEO Yehiel Tal highlighted the company's progress in the development of regenerative medical...
AusperBio to Present AHB-137 Clinical Data Updates at EASL™ Congress 2024
ThePress.net· 1 day agoSAN FRANCISCO, May 28, 2024 /PRNewswire/ -- AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (together AusperBio), a clinical-stage biotechnology company, today ...
A First-In-Class, Broad-Spectrum Antiviral Agent Intending To Revolutionize Treatment of Viral...
St. Joseph News-Press· 16 hours agoSHELTON, CT / ACCESSWIRE / May 29, 2024 / NanoViricides, Inc. (NYSE American: NNVC ) (the...